Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives $13.00 Consensus Price Target from Brokerages
Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average […]
13 Sep 02:58 · The Cerbat Gem